LAB — Standard BioTools Share News
0.000.00%
Last trade - 00:00- $258.47m
- -$217.95m
- $85.33m
Standard BioTools Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Illumina To Buy Somalogic For $350 Million Plus $75 Million In Milestones
Brief: Illumina To Acquire Somalogic, Accelerating Its Proteomics Business
Brief: Standard BioTools Enters Strategic Sale Of SomaLogic To Illumina
Standard BioTools Inc reports results for the quarter ended March 31 - Earnings Summary
Standard BioTools Inc expected to post a loss of 7 cents a share - Earnings Preview
Standard BioTools Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Standard Biotools Announces Preliminary Fourth Quarter And Full Year 2024 Revenue
Brief: Standard Biotools Says Alex Kim Will No Longer Serve As Co’s Chief Operating Officer
Brief: Standard BioTools Appoints Alex Kim As Chief Financial Officer
Standard BioTools Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Standard Biotools Proteomics Profiling Reveals Unique Biomarkers And Insights Into Nonalcoholic Steatohepatitis
Standard BioTools Inc reports results for the quarter ended in June - Earnings Summary
Brief: Standard Biotools Announces Senior Leadership Changes
Brief: Standard BioTools Files For Offering Of Up To 105.1 Mln Common Shares By Selling Securityholders
Brief: Standard Biotools Purchases The Carterra Lsa-Xt System To Accelerate Data Delivery
Brief: Standard Biotools Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Standard BioTools Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Standard Biotools Announces Operational Restructuring Plan To Drive Long-Term Profitable Growth